Ian Karp | Vice President, Investor and Public Relations |
Michael Kauffman | Chief Executive Officer |
Mike Mason | Chief Financial Officer |
Jatin Shah | Senior Vice President, Clinical Development |
Maury Raycroft | Jefferies |
Arlinda Lee | Canaccord Genuity |
Eric Joseph | JPMorgan |
Jonathan Chang | SVB Leerink |
Good morning. My name is Liz and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Fourth Quarter and Full Year 2018 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised, this call is being recorded at the company's request.